Literature DB >> 29280495

TSR2 Induces laryngeal cancer cell apoptosis through inhibiting NF-κB signaling pathway.

Hong-Jiang He1, Han Bing2, Guijun Liu3.   

Abstract

OBJECTIVES/HYPOTHESIS: Human laryngeal squamous cell carcinoma (LSCC) is a malignancy that was discovered originally in the epithelial tissue of laryngeal mucosa. However, the underlying molecular mechanism is still not clear. In this study, we aimed to investigate the potential molecular mechanisms of TSR2 in the LSCC cell apoptosis. STUDY
DESIGN: The expression of TSR2 was first analyzed in LSCC tissues. Then functional effects of TSR2 on Hep-2 and AMC-HN-8 cell lines were performed by overexpression pcDNA3.1-TSR2.
METHODS: We investigated the expression level of TSR2 in LSCC tissues and cells by performing quantitative real-time polymerase chain reaction (qRT-PCR). The pcDNA3.1-TSR2 was constructed to explore the effect of overexpressing TSR2 in Hep-2 cells and AMC-HN-8 cells. We further investigated the effect of overexpressing TSR2 on cell apoptosis-related protein and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 nuclear translocation through Western blot and terminal dUTP nick end-labeling assays.
RESULTS: We found that TSR2 was downregulated in LSSC tissues and cells compared with the controls, and the overexpression of TSR2 in Hep-2 and AMC-HN-8 cells could promote cell apoptosis and related apoptosis proteins. The Western blot/qRT-PCR data further indicated that overexpression of TSR2 in Hep-2 and AMC-HN-8 cells could lead to a block of NF-κB signaling pathway via decreasing nuclear NF-κB p65 and increasing cytoplasm NF-κB p65. Moreover, overexpression of TSR2 significantly inhibited the phosphorylation of IκBα and IKKα/β.
CONCLUSIONS: The results indicated that TSR2-induced apoptosis was mediated by inhibiting the NF-κB signaling pathway, which may provide an effective target in gene therapy for LSCC. LEVEL OF EVIDENCE: NA. Laryngoscope, 128:E130-E134, 2018.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Human laryngeal squamous cell carcinoma; NF-κB; TSR2; cell apoptosis

Mesh:

Substances:

Year:  2017        PMID: 29280495     DOI: 10.1002/lary.27035

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.

Authors:  Ryo Takata; Atsushi Takahashi; Masashi Fujita; Yukihide Momozawa; Edward J Saunders; Hiroki Yamada; Kazuhiro Maejima; Kaoru Nakano; Yuichiro Nishida; Asahi Hishida; Keitaro Matsuo; Kenji Wakai; Taiki Yamaji; Norie Sawada; Motoki Iwasaki; Shoichiro Tsugane; Makoto Sasaki; Atsushi Shimizu; Kozo Tanno; Naoko Minegishi; Kichiya Suzuki; Koichi Matsuda; Michiaki Kubo; Johji Inazawa; Shin Egawa; Christopher A Haiman; Osamu Ogawa; Wataru Obara; Yoichiro Kamatani; Shusuke Akamatsu; Hidewaki Nakagawa
Journal:  Nat Commun       Date:  2019-09-27       Impact factor: 14.919

2.  lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway.

Authors:  Yan Liu; Xinyi Liu; Xiaofeng Zhang; Jinhu Deng; Jian Zhang; Hao Xing
Journal:  Cancer Manag Res       Date:  2020-04-21       Impact factor: 3.989

3.  Knockdown of ectodysplasin-A receptor-associated adaptor protein exerts a tumor-suppressive effect in tongue squamous cell carcinoma cells.

Authors:  Meng Li; Yu-Ting Bai; Kun Han; Xiao-Dong Li; Jian Meng
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.